Perspectives for the Use of Bacterial Lysates for the Treatment of Allergic Rhinitis: A Systematic Review

Overview

Journal J Asthma Allergy

Publisher Dove Medical Press

Date 2022 Jun 30

PMID 35769192

Authors

Kamil Janeczek

Agnieszka Kaczynska

Andrzej Emeryk

Cemal Cingi

Affiliations

Soon will be listed here.

Abstract

Bacterial lysates (BLs) are mixtures of bacterial antigens that have been used for many decades to minimize the risk of recurrent respiratory tract infections in both pediatric and adult populations. Research on the use of BLs is also conducted in allergology. Biomedical databases were searched for articles on the use of BLs in the treatment of allergic rhinitis (AR). After rejecting ineligible articles, six remaining reports were reviewed. Based on this review, it can be concluded that adding BL to standard therapy for seasonal or perennial AR reduces the severity of nasal symptoms and the need for antiallergic medications in both children and adults. Concurrently, these formulations have a high safety profile. An analysis of studies shows that the first effects of BLs therapy appear at the earliest 2-6 weeks after the start of treatment and persist at least 3 months after treatment.

Citing Articles

A Review of Recent Progress in the Mechanisms and Effectiveness of Acupuncture for Treating Allergic Rhinitis.

Bu F, Lou Z Int J Gen Med. 2025; 18():1-10.

PMID: 39790716 PMC: 11708199. DOI: 10.2147/IJGM.S501158.

A Comparative Analysis of the Efficacy of Bacterial Lysate versus Antibiotic Therapy in the Treatment of Experimental Peri-Implantitis in Rats.

Ancuta D, Alexandru D, tucureanu C, Coman C Microorganisms. 2024; 12(8).

PMID: 39203379 PMC: 11356466. DOI: 10.3390/microorganisms12081537.

Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer.

Rahman M, Grice I, Ulett G, Wei M J Immunol Res. 2024; 2024:4312908.

PMID: 38962577 PMC: 11221958. DOI: 10.1155/2024/4312908.

Effect of immunostimulation with bacterial lysate on the clinical course of allergic rhinitis and the level of γδT, iNKT and cytotoxic T cells in children sensitized to grass pollen allergens: A randomized controlled trial.

Janeczek K, Kowalska W, Zarobkiewicz M, Suszczyk D, Mikolajczyk M, Markut-Miotla E Front Immunol. 2023; 14:1073788.

PMID: 36733480 PMC: 9887322. DOI: 10.3389/fimmu.2023.1073788.

References

Li C, Zhou H, Zhang W, Che D . Bacterial lysate treatment in allergic disease: A systematic review and meta-analysis. Pediatr Allergy Immunol. 2021; 32(8):1813-1823. PMC: 8597000. DOI: 10.1111/pai.13572. View

De Benedetto F, Sevieri G . Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art. Multidiscip Respir Med. 2013; 8(1):33. PMC: 3679713. DOI: 10.1186/2049-6958-8-33. View

Chen J, Zhou Y, Nie J, Wang Y, Zhang L, Shi Q . Bacterial lysate for the prevention of chronic rhinosinusitis recurrence in children. J Laryngol Otol. 2017; 131(6):523-528. DOI: 10.1017/S0022215117000524. View

Cingi C, Bayar Muluk N, Scadding G . Will every child have allergic rhinitis soon?. Int J Pediatr Otorhinolaryngol. 2018; 118:53-58. DOI: 10.1016/j.ijporl.2018.12.019. View

Sterne J, Savovic J, Page M, Elbers R, Blencowe N, Boutron I . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898. DOI: 10.1136/bmj.l4898. View

Rossberg S, Keller T, Icke K, Siedmann V, Lau I, Keil T . Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: Follow-up of a randomized trial. Allergy. 2020; 75(8):2020-2025. DOI: 10.1111/all.14247. View

Bodemer C, Guillet G, Cambazard F, Boralevi F, Ballarini S, Milliet C . Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study. PLoS One. 2017; 12(3):e0161555. PMC: 5363804. DOI: 10.1371/journal.pone.0161555. View

Asher M, Montefort S, Bjorksten B, Lai C, Strachan D, Weiland S . Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006; 368(9537):733-43. DOI: 10.1016/S0140-6736(06)69283-0. View

Koatz A, Coe N, Ciceran A, Alter A . Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections. Lung. 2016; 194(4):687-97. PMC: 7087659. DOI: 10.1007/s00408-016-9880-5. View

10.

Cazzola M, Anapurapu S, Page C . Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis. Pulm Pharmacol Ther. 2011; 25(1):62-8. DOI: 10.1016/j.pupt.2011.11.002. View

11.

Banche G, Allizond V, Mandras N, Garzaro M, Cavallo G, Baldi C . Improvement of clinical response in allergic rhinitis patients treated with an oral immunostimulating bacterial lysate: in vivo immunological effects. Int J Immunopathol Pharmacol. 2007; 20(1):129-38. DOI: 10.1177/039463200702000115. View

12.

Small P, Keith P, Kim H . Allergic rhinitis. Allergy Asthma Clin Immunol. 2018; 14(Suppl 2):51. PMC: 6156899. DOI: 10.1186/s13223-018-0280-7. View

13.

Rosenwasser L . Current understanding of the pathophysiology of allergic rhinitis. Immunol Allergy Clin North Am. 2011; 31(3):433-9. DOI: 10.1016/j.iac.2011.05.009. View

14.

Meirlaen L, Levy E, Vandenplas Y . Prevention and Management with Pro-, Pre and Synbiotics in Children with Asthma and Allergic Rhinitis: A Narrative Review. Nutrients. 2021; 13(3). PMC: 7999316. DOI: 10.3390/nu13030934. View

15.

Holt P . Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur Respir J. 1993; 6(1):120-9. View

16.

Janeczek K, Emeryk A, Rapiejko P . Effect of polyvalent bacterial lysate on the clinical course of pollen allergic rhinitis in children. Postepy Dermatol Alergol. 2019; 36(4):504-505. PMC: 6791147. DOI: 10.5114/ada.2019.87457. View

17.

Yin J, Xu B, Zeng X, Shen K . Broncho-Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta-analysis. Int Immunopharmacol. 2017; 54:198-209. DOI: 10.1016/j.intimp.2017.10.032. View

18.

Sih T, Mion O . Allergic rhinitis in the child and associated comorbidities. Pediatr Allergy Immunol. 2009; 21(1 Pt 2):e107-13. DOI: 10.1111/j.1399-3038.2009.00933.x. View

19.

Hallit S, Raherison C, Malaeb D, Hallit R, Kheir N, Salameh P . The AAA Risk Factors Scale: A New Model to Screen for the Risk of Asthma, Allergic Rhinitis and Atopic Dermatitis in Children. Med Princ Pract. 2018; 27(5):472-480. PMC: 6243911. DOI: 10.1159/000490704. View

20.

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View